COVID-19

Clinical Resources

Materials for Providers

Alphabetical by Title

Checklist of Current Versions of U.S. COVID-19 Vaccination Guidance and Clinic Support Tools

Checklist of links to key COVID-19 vaccination resources, including the date they were last revised.

Standing Orders for Administering 2025-2026 Formula Adjuvanted Protein COVID-19 Vaccine to Individuals 12 Years and Older

Eligible healthcare professionals may administer Nuvaxovid (Sanofi-Novavax) COVID-19 vaccine to individuals 12 years of age and older, following clinical guidance from CDC (Interim Clinical Considerations for Use of COVID-19 Vaccines). A list of high-risk conditions supported by evidence is provided, along with a list of conditions that should trigger use of the dosing schedule for people with moderate or severe immunocompromise. CDC recommends COVID-19 vaccination of any person age 6 months or older following a shared clinical decision-making discussion. Links to current COVID-19 vaccine recommendations from AAP, AAFP, IDSA, and ACOG are also provided. These organizations recommend routine vaccination for designated people at increased risk of infection or severe disease and shared clinical decision-making for those at lower risk.

Standing Orders for Administering 2025-2026 Formula mRNA COVID-19 Vaccine to Children 6 Months through 11 Years

Eligible healthcare professionals may administer mRNA COVID-19 vaccines to children 6 months through 11 years, following clinical guidance from CDC (Interim Clinical Considerations for Use of COVID-19 Vaccines). A list of high-risk conditions supported by evidence is provided, along with a list of conditions that should trigger use of the dosing schedule for people with moderate or severe immunocompromise. CDC recommends COVID-19 vaccination of any person age 6 months or older following a shared clinical decision-making discussion. Links to current COVID-19 vaccine recommendations from AAP, AAFP, and IDSA are also provided. These organizations recommend routine vaccination for designated people at increased risk of infection or severe disease and shared clinical decision-making for those at lower risk.

Standing Orders for Administering 2025-2026 Formula mRNA COVID-19 Vaccine to Individuals 12 Years and Older

Eligible healthcare professionals may administer mRNA COVID-19 vaccines to individuals 12 years of age and older, following clinical guidance from CDC (Interim Clinical Considerations for Use of COVID-19 Vaccines). A list of high-risk conditions supported by evidence is provided, along with a list of conditions that should trigger use of the dosing schedule for people with moderate or severe immunocompromise. CDC recommends COVID-19 vaccination of any person age 6 months or older following a shared clinical decision-making discussion. Links to current COVID-19 vaccine recommendations from AAP, AAFP, IDSA, and ACOG are also provided. These organizations recommend routine vaccination for designated people at increased risk of infection or severe disease and shared clinical decision-making for those at lower risk.

Materials for Vaccine Recipients

Alphabetical by Title

How mRNA COVID-19 Vaccines Work (CDC)

How Protein Subunit COVID-19 Vaccines Work (CDC)

CDC · FDA · State

ACIP Recommendations

Current Recommendations

Use of Additional Doses of 2024–2025 COVID-19 Vaccine for Adults Aged ≥65 Years and Persons Aged ≥6 Months with Moderate or Severe Immunocompromise: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
MMWR December 12, 2024 / 73(49);1118–1123
Use of COVID-19 Vaccines for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024–2025
MMWR: Early Release September 10, 2024, 73

Vaccine Information Statements

COVID-19 Vaccine VIS
Updated: January 31, 2025

FDA Package Inserts & Vaccine Fact Sheets (EUA)

COVID-19: Mnexspike Package Insert
Moderna
COVID-19: Nuvaxovid Package Insert
Novavax, Inc
COVID-19: Comirnaty Package Insert
Pfizer-BioNTech
COVID-19: Spikevax Package Insert
Moderna

Healthcare Professional Organizations

Vaccine Recommendations

IDSA 2025 Guidelines on the Use of Vaccines for the Prevention of Seasonal COVID-19, Influenza, and RSV Infections in Immunocompromised Patients
To support evidence-based clinical & shared decision-making during the 2025-2026 respiratory tract infection season, IDSA developed rapid guidelines for the use of U.S-licensed vaccine against COVID-19, Influenza, and RSV in adult and pediatric patients who are immunocompromised.
11/18/2025. IDSA Practice Advisory
The Infectious Diseases Society of America (IDSA) develops evidence-based immunization policy and recommendations to prevent infectious diseases across populations. Its recommendations include immunocompromised patients.
AAP Recommendations for COVID-19 Vaccines in Infants, Children, and Adolescents: Policy Statement
This policy statement updates the recommendations of the AAP for the use of coronavirus disease 2019 (COVID-19) vaccines in the prevention of severe COVID-19 in children.
10/20/2025. Pediatrics; doi: 10.1542/peds.2025-073924
The American Academy of Pediatrics (AAP) is a leading professional organization that develops evidence-based immunization policy and clinical guidance to protect the health of infants, children, and adolescents. AAP supports pediatric clinicians with education, tools, and advocacy to improve vaccination coverage and safety.
PALTmed Recommendations for COVID-19 Vaccine in Post-Acute and Long-Term Care Residents and Staff
PALTmed’s Infection Advisory Committee has developed recommendations for the 2025–2026 COVID-19 vaccine to guide clinicians and administrators in post-acute and long-term care settings.
10/14/2025. JAMDA; DOI: 10.1016/j.jamda.2025.106002
The Post-Acute and Long-Term Care Medical Association (PALTmed) promotes immunization policies and recommendations to protect residents and staff in post-acute and long-term care settings.
ACOG Practice Advisory — COVID-19 Vaccination Considerations for Obstetric–Gynecologic Care
This Practice Advisory provides an overview of the currently available COVID-19 vaccines and guidance for their use in individuals contemplating pregnancy and in pregnant, recently pregnant, and lactating individuals.
10/2025. ACOG Practice Advisory
The American College of Obstetricians and Gynecologists (ACOG) develops and promotes clinical guidance for safe and effective vaccination of pregnant and reproductive-age patients.
AAFP Fall 2025 Immunization Recommendations
The AAFP has released their fall immunization recommendations, reinforcing a commitment to the health of communities across the country. The AAFP urges all adults, children and families to stay up to date on recommended vaccines to keep themselves and their loved ones healthy.
9/8/2025. AAFP Recommendation Statement.
The AAFP is the largest national association of family physicians and supports evidence-based immunization practices for patients of all ages.
SHEA Reaffirms Support for COVID-19 Vaccination Among Healthcare Personnel, Including Pregnant Staff
SHEA supports healthcare personnel (HCP), including pregnant HCP, to be free to choose to continue to get vaccinated against COVID-19 to protect them and their patients from the COVID-19 virus.
5/28/2025. The Society for Healthcare Epidemiology of America
The Society for Healthcare Epidemiology of America (SHEA) develops immunization recommendations to prevent healthcare-associated infections and protect both patients and healthcare personnel.

Travel

All travelers should be up to date on routine vaccines. Depending on the destination, itinerary, and duration of travel, additional vaccines may be recommended.

CDC Resources

Travelers’ health information for healthcare providers

Partner Resources

Non-Governmental

The American Pharmacists Associationʼs resources and information on COVID 19, including vaccines, testing, education activities, webinars, practice resources, and advocacy opportunities.
Access WHOʼs COVID-19 resources, including public advice, Q&As, regulation and policy, news, vaccine manufacturers, and more.

More from Immunize.org

This page was updated on .